MTD Mettler-Toledo International, Inc. Common Stock

NYSE · US · Healthcare · Diagnostics & Research · mt.com

1491.02USD+0.33%Mkt Cap: 29.78B $P/E: 34.03Today

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Wes…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc Common Stock

$242.11BUSDP/E 35.5

DHR

Danaher Corporation Common Stock

$150.48BUSDP/E 38.2

NTRA

Natera, Inc. - Common Stock

Agilent Technologies, Inc. Common Stock

$47.30BUSDP/E 33.1

IQV

IQVIA Holdings, Inc. Common Stock

$42.50BUSDP/E 32.2

WAT

Waters Corporation Common Stock

$41.75BUSDP/E 107.4

ILMN

Illumina, Inc. - Common Stock

$41.23BUSDP/E 50.8

IDXX

IDEXX Laboratories, Inc. - Common Stock

$40.89BUSDP/E 36.4

DGX

Quest Diagnostics Incorporated Common Stock

$25.75BUSDP/E 25.0

Labcorp Holdings Inc. Common Stock

$25.02BUSDP/E 25.5

Guardant Health, Inc. - Common Stock

$23.86BUSD

RVTY

Revvity, Inc. Common Stock

$16.91BUSDP/E 72.5

MEDP

Medpace Holdings, Inc. - Common Stock

$16.73BUSDP/E 35.2

ERF

Eurofins Scientific SE

$14.05BUSDP/E 26.2

CRL

Charles River Laboratories International, Inc. Common Stock

$13.85BUSD

ICLR

ICON plc - Ordinary Shares

Qiagen N.V. Common Shares

$9.24BUSDP/E 22.7

GRAL

GRAIL, Inc. - Common Stock

$6.40BUSD

Key Statistics

Company

Market Cap29.78B USD

Enterprise Value31.86B USD

Revenue (TTM)4.13B USD

Gross Profit2.39B USD

Net Income (TTM)869.19M USD

Revenue/Share203.41 USD

Last Price1491.02 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees16.6K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)34.03

P/E (Forward)28.73

PEG2.76

EV/EBITDA24.98

EV/Revenue7.71

P/S7.20

P/B2322.17

EPS (TTM)44.37

EPS (Forward)51.73

52W Range

1023.0588% of range1554.78

52W High1554.78 USD

52W Low1023.05 USD

Profitability

Gross Margin59.37%

Oper. Margin31.20%

EBITDA Margin30.86%

Profit Margin21.59%

ROE-3677.41%

ROA23.41%

Growth

Revenue Growth4.50%

Earnings Growth18.30%

Cash Flow & Leverage

Operating CF955.77M USD

CapEx (TTM)107.12M USD

FCF Margin16.78%

FCF Yield2.33%

Net Debt2.09B USD

Net Debt/EBITDA1.64

Balance Sheet

Debt/Equity-91.05

Current Ratio1.12

Quick Ratio0.66

Book Value/Sh0.64 USD

Cash/Share2.56 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.6 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)1458.08 USD

Upside (mean)-2.2%

Target Range1200.00 USD – 1600.00 USD

1200.00-2.2% to mean1600.00

# Analysts13

Ownership

Shares Out.20.04M

Float19.93M

Insiders0.44%

Institutions105.25%

Short Interest

Short Ratio3.9d

Short % Float4.00%

Short % Out.3.48%

Shares Short697.79K

Short (prev mo.)719.93K

Technical

SMA 501408.47 (+5.9%)

SMA 2001318.60 (+13.1%)

Beta1.22

S&P 52W Chg14.58%

Avg Vol (30d)195.39K

Avg Vol (10d)187.93K

Technical Indicators

RSI (14)59.6

MACD38.8440

MACD Signal31.3971

MACD Hist.+7.4469

BB Upper1605.87 USD

BB Middle1416.90 USD

BB Lower1227.94 USD

BB Width26.67%

ATR (14)39.90 USD

Vol Ratio (20d)0.60x